A detailed history of E Fund Management Co., Ltd. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,784 shares of RVMD stock, worth $466,839. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,784
Previous 11,274 4.35%
Holding current value
$466,839
Previous $437,000 11.67%
% of portfolio
0.03%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$36.92 - $47.94 $18,090 - $23,490
-490 Reduced 4.35%
10,784 $488,000
Q2 2024

Aug 12, 2024

SELL
$30.14 - $40.68 $65,222 - $88,031
-2,164 Reduced 16.1%
11,274 $437,000
Q1 2024

May 13, 2024

SELL
$26.56 - $33.55 $161,856 - $204,453
-6,094 Reduced 31.2%
13,438 $433,000
Q4 2023

Feb 06, 2024

BUY
$18.35 - $34.12 $144,542 - $268,763
7,877 Added 67.58%
19,532 $560,000
Q3 2023

Nov 13, 2023

SELL
$25.17 - $35.05 $146,338 - $203,780
-5,814 Reduced 33.28%
11,655 $323,000
Q2 2023

Aug 11, 2023

SELL
$20.28 - $27.0 $22,997 - $30,618
-1,134 Reduced 6.1%
17,469 $467,000
Q1 2023

May 11, 2023

BUY
$20.76 - $30.09 $127,923 - $185,414
6,162 Added 49.53%
18,603 $403,000
Q4 2022

Feb 14, 2023

SELL
$17.68 - $25.53 $105,655 - $152,567
-5,976 Reduced 32.45%
12,441 $296,000
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $115,445 - $171,912
6,612 Added 56.01%
18,417 $363,000
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $129,275 - $241,568
8,891 Added 305.11%
11,805 $230,000
Q1 2021

May 12, 2021

BUY
$37.21 - $54.43 $108,429 - $158,609
2,914 New
2,914 $133,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.